These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9266781

  • 1. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD, Kronenberg MW, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S, Smith JJ, Kilcoyne L, Dolan N, Edens TR, Metherall J, Konstam MA.
    Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S.
    Circulation; 1996 Aug 15; 94(4):690-7. PubMed ID: 8772689
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
    Konstam MA, Kronenberg MW, Udelson JE, Kinan D, Metherall J, Dolan N, Edens T, Howe D, Kilcoyne L, Benedict C.
    Am J Cardiol; 1992 Jun 15; 69(19):1591-5. PubMed ID: 1598875
    [Abstract] [Full Text] [Related]

  • 4. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 15; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 5. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S, Arita M, Ueno Y, Shiotani M, Nakatsu C, Nakamura Y, Hano T, Nishio I, Masuyama Y.
    J Cardiol; 1991 Nov 15; 21(1):115-24. PubMed ID: 1687786
    [Abstract] [Full Text] [Related]

  • 6. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1992 Aug 15; 86(2):431-8. PubMed ID: 1638712
    [Abstract] [Full Text] [Related]

  • 7. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Aug 15; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.
    Akbulut T, Akgöz H, Dayi SU, Celik SE, Gürkan U, Tayyareci G.
    Angiology; 2006 Aug 15; 57(2):181-6. PubMed ID: 16518525
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
    Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.
    J Am Coll Cardiol; 1998 Feb 15; 31(2):419-25. PubMed ID: 9462588
    [Abstract] [Full Text] [Related]

  • 10. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.
    Am Heart J; 1999 Nov 15; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [Abstract] [Full Text] [Related]

  • 11. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
    Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):916-23. PubMed ID: 10091816
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing exercise performance in patients with left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction.
    Kronenberg MW, Konstam MA, Edens TR, Howe DM, Dolan N, Udelson JE, Benedict C, Stewart D, Yusuf S.
    J Card Fail; 1998 Sep 01; 4(3):159-67. PubMed ID: 9754586
    [Abstract] [Full Text] [Related]

  • 14. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV, Dries DL, Domanski MJ, Cohn JN.
    N Engl J Med; 2001 May 03; 344(18):1351-7. PubMed ID: 11333991
    [Abstract] [Full Text] [Related]

  • 15. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Am J Kidney Dis; 2020 Jan 03; 75(1):21-29. PubMed ID: 31303349
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
    Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang CS, Konstam MA, Greenberg B.
    Am J Cardiol; 1995 Jun 01; 75(16):1151-7. PubMed ID: 7762503
    [Abstract] [Full Text] [Related]

  • 17. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S.
    Eur J Heart Fail; 2014 Mar 01; 16(3):325-33. PubMed ID: 24464788
    [Abstract] [Full Text] [Related]

  • 18. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Mar 01; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 19. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV, Carstensen S, Caidahl K, Nilsen DW, Edner M, Lindvall K, Snapinn SM, Berning J.
    Am Heart J; 1996 Jul 01; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [Abstract] [Full Text] [Related]

  • 20. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M, Cardei S, de Arcangelis E, Monteforte I, Capaldo M, Muto P, Marchegiano R, Kilama MO, Condorelli M.
    Am Heart J; 1997 Mar 01; 133(3):268-72. PubMed ID: 9060793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.